Table 3. Effectiveness of Different UVB Wavelengths for Moderate-To-Severe Plaque Psoriasis.
| Study | Comparison of Clinical Outcomes by Ultraviolet Source | |||
|---|---|---|---|---|
| Kirke et al. (89) 2007; N=100 | NB-UVB vs. Selective UVB | |||
| Treat Till Clear | Complete clearance |
Number of Treatments to Clearance |
Mean Cumulative UVB Dose until Clearance, J/cm2 (95% CI) |
Remission at 6 months |
| NB-UVB (3x wkly) Treat to Clear | 28/50 (56%) | 28.4 | 40.9 (28.1, 55.2) | 1/19 |
| Selective UVB (3x wkly) | 20/50 (40%) | 30.4 | 39.9 (27.4, 53.6) | 0/13 |
|
|
OR = 2.00 (0.87, 4.62) |
|
|
|
|
NSD |
NSD |
NSD |
||
| Yuehua et al. (88) 2008; N=73 | NB-UVB vs. BB-UVB | |||
| 6 wk Treatment (18 sessions) |
PASI-60 | PASI ± SD Pre / Post |
Mean Cumulative UVB Dose, J/cm2 ± SD |
Durability |
| NB-UVB (3x wkly) | 36/43 (84%) | 11.2 ± 3.6/ 2.9 ± 1.3 |
16.10 ± 4.13 | NR |
| BB-UVB (3x wkly) | 11/29 (38%) | 11.6 ± 4.1/ 2.2 ± 0.9 |
16.10 ± 4.13 | NR |
| p < .01 | NSD | NSD | ||
NR, Not reported; NSD, Not statistically different